These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24621146)

  • 1. Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease.
    Riccio E; Esposito G; Franzone A; Imbriaco M; Santangelo M; Pisani A
    J Clin Hypertens (Greenwich); 2014 May; 16(5):385-6. PubMed ID: 24621146
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension.
    Klein IHHT; Ligtenberg G; Oey PL; Koomans HA; Blankestijn PJ
    J Am Soc Nephrol; 2001 Nov; 12(11):2427-2433. PubMed ID: 11675419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of percutaneous renal denervation on blood pressure level and sympathetic activity in a patient with polycystic kidney disease.
    Prejbisz A; Kądziela J; Lewandowski J; Florczak E; Zylińska E; Kłopotowski M; Witkowski A; Januszewicz A
    Clin Res Cardiol; 2014 Mar; 103(3):251-3. PubMed ID: 24322784
    [No Abstract]   [Full Text] [Related]  

  • 4. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB; Johnson A; Gabow PA; Schrier RW
    N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polycystic kidneys].
    Burtey S; Berland Y
    Rev Prat; 2009 Jun; 59(6):837-8. PubMed ID: 19642442
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal central control underlies impaired baroreflex control of heart rate and sympathetic nerve activity in female Lewis polycystic kidney rats.
    Salman IM; Phillips JK; Ameer OZ; Hildreth CM
    J Hypertens; 2015 Jul; 33(7):1418-28. PubMed ID: 26039532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal-dominant polycystic kidney disease and hypertension: a review.
    Florijn KW; van Saase JL; Breuning MH; Chang PC
    Contrib Nephrol; 1992; 97():71-92. PubMed ID: 1386018
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical aspects of polycystic disease of the kidney in the adult].
    Aniceto J; Milhomens C; da Costa AG; Barbas JM; Correia AM; Pinto JL; de Almeida OM; Prata MM
    Acta Med Port; 1985; 6(9-12):243-7. PubMed ID: 3832814
    [No Abstract]   [Full Text] [Related]  

  • 9. Polycystic kidney disease and the flyer.
    Rayman RB
    Aviat Space Environ Med; 1985 Nov; 56(11):1105-6. PubMed ID: 4074266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults.
    Handa SP
    Clin Invest Med; 2006 Dec; 29(6):339-46. PubMed ID: 17330449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic cyst marsupialization in patients with autosomal dominant polycystic kidney disease.
    Dunn MD; Portis AJ; Naughton C; Shalhav A; McDougall EM; Clayman RV
    J Urol; 2001 Jun; 165(6 Pt 1):1888-92. PubMed ID: 11371874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease.
    Cerasola G; Li Vecchi M; Mulé G; Cottone S; Mangano MT; Andronico G; Contomo A; Parrino IA; Renda F; Pavone G; Scialabba A
    Contrib Nephrol; 1997; 122():22-7. PubMed ID: 9399032
    [No Abstract]   [Full Text] [Related]  

  • 13. The association of aldosterone-producing adrenal adenoma in a patient with autosomal dominant polycystic kidney disease.
    Liou HH; Tsai SC; Chen WJ; Huang TP; Huang WJ; Chen KK
    Am J Kidney Dis; 1994 May; 23(5):739-42. PubMed ID: 8172219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmoregulation in Polycystic Kidney Disease: Relationship with Cystogenesis and Hypertension.
    Underwood CF; Phillips JK; Hildreth CM
    Ann Nutr Metab; 2018; 72 Suppl 2():33-38. PubMed ID: 29925070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant polycystic kidney disease: presentation, complications, and prognosis.
    Delaney VB; Adler S; Bruns FJ; Licinia M; Segel DP; Fraley DS
    Am J Kidney Dis; 1985 Feb; 5(2):104-11. PubMed ID: 3970015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic response to volume expansion in polycystic kidney disease.
    Torres VE; Wilson DM; Offord KP; Burnett JC; Romero JC
    Mayo Clin Proc; 1989 May; 64(5):509-15. PubMed ID: 2725063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological evaluation of sympathetic renal innervation in patients with autosomal dominant polycystic kidney disease.
    Rovella V; Scimeca M; Giannini E; D'Ercole A; Giacobbi E; Noce A; D'Urso G; Anselmo A; Bove P; Santeusanio G; Bonanno E; Casasco M; Mauriello S; Di Daniele N; Mauriello A; Anemona L
    J Nephrol; 2020 Feb; 33(1):83-89. PubMed ID: 31025246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncontrolled hypertension and hyperreninemia after hemorrhage in a patient with end-stage renal disease and acquired renal cysts.
    Bongu S; Faubert PF; Porush JG; Gulmi F
    J Am Soc Nephrol; 1994 Jul; 5(1):22-6. PubMed ID: 7948780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and evaluation of renal cysts.
    Waterman J
    Prim Care; 2014 Dec; 41(4):823-35. PubMed ID: 25439536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R; Hinderliter AL
    Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.